Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Knight Therapeutics Inc T.GUD

Alternate Symbol(s):  KHTRF

Knight Therapeutics Inc. is a Canada-based specialty pharmaceutical company. The Company's principal business activity includes developing, acquiring, in-licensing, out-licensing, manufacturing, marketing and distributing pharmaceutical products in Canada, Latin America and select international markets. It finances other life sciences companies and secures product distribution rights for Canada... see more

TSX:GUD - Post Discussion

Knight Therapeutics Inc > Correction ... Goodman added more
View:
Post by MrMugsy on Nov 23, 2021 7:31am

Correction ... Goodman added more

Correction ... add another 18,000 shares to Goodman's holdings ... came through a little later.
That's a lot of insider activity

Filed 2021-11-22 22:19
 
Tx date 2021-11-22
$GUD
Knight Therapeutics Inc.
Long Zone Holdings Inc.
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$95,220
+18,000 vol
$5.29 each
21,685,133  
Filed 2021-11-22 16:55
 
Tx date 2021-11-22
$GUD
Knight Therapeutics Inc.
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$4,184
+800 vol
$5.23 each
672,984  
Filed 2021-11-22 16:52
 
Tx date 2021-11-22
$GUD
Knight Therapeutics Inc.
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Holder: Long Zone Holdings Inc. (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market
$95,220
+18,000 vol
$5.29 each
21,541,233
 
Comment by EbbFlow88 on Nov 23, 2021 8:40am
From the share count on the right, it looks like more than that unless I'm missing something. There's a 143,900 share difference. Maybe more transactions are not showing?
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities